FDA 483 - Meito Sangyo Co., Ltd - April 04, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Meito Sangyo Co., Ltd in Nagoya, Japan, a manufacturer of human food and dietary supplements, was cited for significant deficiencies during an FDA inspection. The firm failed to establish adequate specifications for dietary supplement ingredients and finished products, lacked master manufacturing records, and maintained incomplete batch production records. Additionally, the facility exhibited unsanitary conditions and equipment in disrepair, posing risks to product quality and safety.
ID · b6779993-cfe8-4d91-8c97-e864d3432510